Iclusig: A Breakthrough In The Treatment Of Drug-Resistant Leukemia
In a significant advancement in the fight against leukemia, Iclusig (ponatinib) continues to demonstrate its…
Articles
How to Use Aspaveli (Pegcetacoplan) Safely: A Complete Patient Handbook
Introduction Aspaveli (pegcetacoplan) is a C3 complement inhibitor used for the treatment of paroxysmal nocturnal…
Qalsody: A Milestone In The Treatment Of Acromegaly
April 2023 – The U.S. Food and Drug Administration (FDA) today approved Qalsody (tofersen) for…
New Hepatitis B Treatment Pradefovir Mesylate Approved In China, Bringing New Hope To Chronic Hepatitis B Patients
China’s National Drug Administration (NMPA) has officially approved the marketing application for the novel anti-hepatitis…
Jaypirca (Pitobutinib) Offers New Hope For Patients With Relapsed Refractory Hematologic Tumors
Recently, the U.S. Food and Drug Administration (FDA) announced the accelerated approval of Jaypirca (generic…
Alkindi Hydrocortisone: A Comprehensive Guide 2025
In this blog, DengYue will explore the following aspects of Alkindi Hydrocortisone: Advantages over traditional…
Talzenna Approved By FDA, Bringing New Targeted Treatment Options To Breast Cancer Patients
In October 2018, the U.S. Food and Drug Administration (FDA) approved talazoparib, a novel PARP…
Novel Drug Tavneos Offers New Hope For Patients With ANCA-Associated Vasculitis
In October 2021, the U.S. Food and Drug Administration (FDA) approved a novel drug, Tavneos…
A Patient’s Guide to Agamree (Vamorolone): Uses, Benefits, and Safety
What is Agamree (Vamorolone)? Agamree Vamorolone, also known by its generic name Vamorolone, is a…
Garsorasib Company Announces Breakthrough In Targeted Cancer Therapy For Patients With KRAS G12C Mutation
Garsorasib Company Today announced a significant milestone in the development of its flagship drug, Garsorasib, a…